Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary sclerosing cholangitis--an immunologically mediated disease?

R W Chapman, D P Jewell

    The Western Journal of Medicine
    |August 1, 1985
    PubMed
    Summary

    Primary sclerosing cholangitis (PSC) is a chronic biliary disease often linked with ulcerative colitis. Research suggests PSC may be an immune-mediated condition triggered by gut bacteria antigens in susceptible individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease.

    Inflammatory bowel diseases·2013
    Same author

    Association of caspase-9 and RUNX3 with inflammatory bowel disease.

    Tissue antigens·2010
    Same author

    The genetics of NOD-like receptors in Crohn's disease.

    Tissue antigens·2010
    Same author

    Confirmation of the novel association at the BTNL2 locus with ulcerative colitis.

    Tissue antigens·2009
    Same author

    MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease.

    Mucosal immunology·2009
    Same author

    Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort.

    Inflammatory bowel diseases·2009

    Area of Science:

    • Gastroenterology
    • Immunology
    • Hepatology

    Background:

    • Primary sclerosing cholangitis (PSC) is a rare, chronic liver disease causing inflammation and fibrosis of the bile ducts.
    • PSC frequently co-occurs with ulcerative colitis (UC), affecting over two-thirds of PSC patients and 3-5% of UC patients.
    • The exact cause of PSC remains unknown, prompting investigation into potential triggers and mechanisms.

    Purpose of the Study:

    • To investigate the immunological basis of Primary Sclerosing Cholangitis (PSC).
    • To explore the association between PSC, ulcerative colitis, and potential microbial triggers.
    • To identify potential autoantibodies and genetic markers linked to PSC development.

    Main Methods:

    • Review of existing literature on PSC and ulcerative colitis.
    • Analysis of associations with human leukocyte antigens (HLA) B8 and DR3.
    • Detection of circulating autoantibodies against colon and portal tract antigens.
    • Investigation of cross-reactivity between anticolon antibodies and enteric Escherichia coli.

    Main Results:

    • PSC shows a strong association with HLA-B8 and HLA-DR3.
    • Autoantibodies targeting the colon and portal tract are common in PSC patients.
    • The anticolon antibody demonstrates cross-reactivity with enteric Escherichia coli.
    • A hypothesis is proposed linking PSC to immunization with shared antigens between gut microbes and the biliary system in susceptible UC patients.

    Conclusions:

    • Primary sclerosing cholangitis is likely an immunologically mediated disease.
    • Enteric microorganisms may play a role in triggering PSC in genetically susceptible individuals with ulcerative colitis.
    • Further research is warranted to elucidate the precise immunological pathways and microbial triggers involved in PSC pathogenesis.

    Related Experiment Videos